Will new weight loss drugs save or bankrupt the NHS?
New weight loss drugs known commercially as Wegovy and Mounjaro have been demonstrated to have a big effect in helping people to lose weight, and have recently been approved for use in obesity treatment in the NHS in England. In total, 4.1 million people would meet the criteria to be eligible to take one of these drugs. That seems fantastic - an end to obesity in our time. The problem is can we afford these drugs without bankrupting the NHS? How badly do we need them? But will this work? Should we be more ambitious? Can this help the NHS? Or bankrupt it? Guests: John Wilding, Professor of…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.